济民健康 (603222)

Chimin Health Management Co., Ltd.

ASH

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 52509.06
  • Circulating A-Shares(W): 52509.06
  • Earnings Per Share(RMB): -0.1473
  • Net Assets Per Share(RMB): 2.6641
  • Operating Revenue(W RMB): 54471.83
  • Total Profit(W RMB): -9070.81
  • **Net Profit Attributable to Parent(W RMB) **: -7715.04
  • Net Profit Growth Rate(%): -371.51
  • Weighted Return on Equity(%): -5.3600
  • Operating Cash Flow Per Share(RMB): -0.0610
  • Undistributed Profit Per Share(RMB): 0.4615
  • Capital Reserve Per Share(RMB): 1.1417

2. Main Business

The main business covers:

  • Medical services
  • Large infusion solutions and medical devices R&D, production, and sales

3. Company Basic Information

  • Company Name: Jimin Health Management Co., Ltd.
  • Listing Date: 2015-02-17
  • Industry: Pharmaceuticals & Healthcare - Medical Devices
  • Address: No. 888 Beiyuan Road, Huangyan District, Taizhou City, Zhejiang Province
  • Website: https://www.chimin.cn
  • Company Profile: The company was established through the lawful overall change of Zhejiang Jimin Pharmaceutical Co., Ltd. into a joint stock company. Approved at the shareholders' meeting of Jimin Co., Ltd. on July 15, 2010, Jimin Co., Ltd. intended to undergo an overall change to establish Jimin Pharmaceutical. Audited by Tianjian Accounting Firm, the audited net assets of Jimin Co., Ltd. as of July 31, 2010 were 182,048,600 yuan. Approved at the shareholders' meeting of Jimin Co., Ltd. on September 10, 2010, 110 million yuan from the aforementioned audited net assets was used as the registered capital of Jimin Pharmaceutical, with the balance recorded as capital reserve. Kunyuan Asset Appraisal Co., Ltd. issued the "Asset Appraisal Report for the Total Equity Value of Shareholders Involved in the Proposed股份制改制 of Zhejiang Jimin Pharmaceutical Co., Ltd." (Kunyuan Pingbao [2010] No. 301), confirming that as of the appraisal base date of July 31, 2010, the assessed value of Jimin Co., Ltd.'s net assets was 210,568,100 yuan. On October 28, 2010, Jimin Pharmaceutical was registered and established with the Taizhou Administration for Industry and Commerce, obtaining a business license.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Shuangge Group Co., Ltd. General Legal Person 12351.85 23.52
2 Taizhou Ziming Trading Co., Ltd. General Legal Person 2853.20 5.43

5. Concept Sectors

  • Private Hospitals
  • Immunotherapy
  • Medical Aesthetics Concept
  • Helicobacter Pylori
  • Innovative Drugs

Remarks

  • Data update date: 2025-11-01
  • Data source: Public market information